000 01309 a2200409 4500
005 20250512203449.0
264 0 _c19850221
008 198502s 0 0 eng d
022 _a0300-9734
024 7 _a10.3109/03009738409179508
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnnerén, G
245 0 0 _aThe presence of normal levels of serum immunoreactive insulin-like growth factor 2 (IGF-2) in patients with Down's syndrome.
_h[electronic resource]
260 _bUpsala journal of medical sciences
_c1984
300 _a274-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aChild
650 0 4 _aDown Syndrome
_xblood
650 0 4 _aFemale
650 0 4 _aFetal Blood
_xanalysis
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInsulin
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPeptides
_xblood
650 0 4 _aPregnancy
650 0 4 _aRadioimmunoassay
650 0 4 _aSomatomedins
_xblood
700 1 _aEnberg, G
700 1 _aSara, V R
773 0 _tUpsala journal of medical sciences
_gvol. 89
_gno. 3
_gp. 274-8
856 4 0 _uhttps://doi.org/10.3109/03009738409179508
_zAvailable from publisher's website
999 _c6240124
_d6240124